FIELD: medicine.
SUBSTANCE: invention relates to oncology, immunology, laboratory diagnostics and is intended for prediction of dissemination of tumour process in patients with stomach cancer. Absolute content of monocytes and concentration of tumour necrosis factor alpha (TNF-α) are determined in peripheral venous blood of examined people. If content of monocytes is lower than 0.35×109 cell/l and TNF-α is higher than 55 pg/ml, high probability of dissemination is predicted.
EFFECT: method makes it possible to reduce time and simplify methods of prediction, as it makes it possible to use materials, reagents and methods of analysis, widely used in standard clinical-laboratory practice.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RISK OF MALIGNANT NEW GROWTHS | 2014 |
|
RU2552305C1 |
| METHOD FOR EVALUATING THE DEGREE OF RISK OF ADVERSE EVALUATION OF DISEASE IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2662085C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN BREAST CANCER PATIENTS AFTER ANTICANCER TREATMENT | 2010 |
|
RU2436099C1 |
| DIAGNOSTIC TECHNIQUE FOR RISK OF ANTITUMOR IMMUNE PROTECTION DEFICIENCY | 2015 |
|
RU2605310C1 |
| METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
| TEST SYSTEM “HV2 mtDNA-PCR” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH GASTRIC CANCER | 2017 |
|
RU2683571C1 |
| METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
| METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
| METHOD FOR PREDICTING SEVERE JAUNDICE OF BENIGN GENESIS | 2018 |
|
RU2677468C1 |
| GASTRIC CANCER IMMUNODIAGNOSIS METHOD | 2023 |
|
RU2818734C1 |
